Health
WuXi Vaccines Establishes New Vaccines CDMO Facility in China
SUZHOU, China, Nov. 15, 2022 /PRNewswire/ -- WuXi Vaccines, a leading global Contract Development and Manufacturing Organization (CDMO), announced that it has entered into an agreement with Harbour BioMed under which Harbour BioMed's manufacturing facility in Suzhou will be transferred to WuXi Va...
2022-11-15 12:45
1790
HARBOUR BIOMED LAUNCHES NONA BIOSCIENCES' "IDEAS TO IND" PRECLINICAL SOLUTIONS BUSINESS TO ACCELERATE GLOBAL BIOTHERAPEUTIC INNOVATION
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Nov. 14, 2022 /PRNewswire/ -- Harbor BioMed (HKEX: 02142) today announced establishment of a wholly-owned subsidiary, Nona Biosciences, to provide next-generation antibody and biotherapeutic solutions to partners from discovery to IND. T...
2022-11-15 12:19
1960
Biotheus has entered into a license and collaboration agreement with Hansoh Pharma for its EGFR/MET bispecific antibody in the Greater China territory
ZHUHAI, China, Nov. 14, 2022 /PRNewswire/ -- Biotheus Inc., a clinical-stage biotech company focused on the discovery and development of biologics for oncology and inflammatory diseases, announced today that they have entered into a collaboration agreement with Hansoh Pharmaceuticals, for Biotheu...
2022-11-15 11:16
2152
VentureBlick Launches Global Search for Healthcare Startups 'Most Endorsed by the Medical Community'
SINGAPORE, Nov. 14, 2022 /PRNewswire/ -- VentureBlick, a fundraising platform matching healthcare startups with medical investors, has launched its worldwide search to identify promising healthcare startups for the medical community to evaluate, advise, and fund. Only startups that receive endors...
2022-11-15 09:00
2788
AIRS Medical showcases award-winning MRI enhancement AI solution at RSNA 2022
SEOUL, South Korea, Nov. 14, 2022 /PRNewswire/ -- AIRS Medical, Inc., a leading medical AI solution provider, announced its participation in the 108th Scientific Assembly and Annual Meeting of the Radiological Society ofNorth America (RSNA 2022), the world's leading annual imaging forum at McC...
2022-11-14 23:00
2555
Shiang Ding Targets US Market With Healthy Herbal Beverage Alternatives
TAIPEI, Nov. 14, 2022 /PRNewswire/ -- Shiang Ding Food Co.
2022-11-14 23:00
2730
The World's First ETa-specific Monoclonal Antibody: Gmax Biopharm's GMA131 Approved by the US FDA for Clinical Study on (DKD) Diabetic Kidney Disease
HANGZHOU, China, Nov. 14, 2022 /PRNewswire/ -- Gmax Biopharm LLC. announced today that its application of investigation of New Drug (IND) for GMA131 injection, the first global ETa-specific monoclonal antibody, was approved by the US FDA onNov 11, 2022 for clinical study on diabetic kidney diseas...
2022-11-14 22:55
2664
Meihua International Medical Technologies Co., Limited Reports Unaudited 2022 First Half Financial Results
YANGZHOU, China, Nov. 14, 2022 /PRNewswire/ -- Meihua International Medical Technologies Co., Limited ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries inChina, today reported its unaudited...
2022-11-14 21:00
2211
Nuance Pharma Announces Clearance of IND Application for Respiratory Syncytial Virus (RSV) Vaccine in China
SHANGHAI, Nov. 13, 2022 /PRNewswire/ -- Nuance Pharma ("the Company") announces the Center for Drug Evaluation ("CDE") has approved its Investigational New Drug ("IND") application supporting its pivotal phase III clinical trial of MVA-BN RSV vaccine against respiratory syncytial virus (RSV) in a...
2022-11-14 09:54
2100
SK Biopharmaceuticals Receives Korea Drug Development Fund Investment Grant to Develop Novel Oncology Candidate, SKL27969
State-run financing to provide two-year support of Phase 1 research for oncology candidate, SKL27969, for the potential treatment of advanced solid tumors SK Biopharmaceuticals to present preclinical data on oncology candidate, SKL27969, at Society for Neuro-Oncology Conference PANGYO, South Ko...
2022-11-14 08:00
2543
Akeso's Ivonescimab (PD-1/VEGF Bispecific Antibody, AK112) Granted Breakthrough Therapy Designation for I-O Resistance NSCLC Patients in China
* AK112 has now been granted three Breakthrough Therapy Designations for NSCLC * The only drug candidate granted Breakthrough Therapy Designation for I-O Resistance NSCLC inChina HONG KONG, Nov. 13 /PRNewswire/ -- Akeso, Biopharma (9926. HK) ("Akeso") announced that the Center for Drug Evaluati...
2022-11-14 08:00
2277
INDUSTRY INNOVATION: AI SMILE Smart Tracking Case debut worldwide developed by Weiyun AI & Robotics Group
SHANGHAI, Nov. 11, 2022 /PRNewswire/ -- In last few decades, experts have been constantly discussing the future trend of AI application in medical scenarios: how to use AI as the underlying technology but actually transform the medical experiences of every individuals? Recently, Weiyun AI & Robot...
2022-11-11 21:35
10693
So-Young to Report Third Quarter 2022 Financial Results on November 18, 2022
BEIJING, Nov. 11, 2022 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it will report its finan...
2022-11-11 18:11
3519
CHOCOLATE TOUCH®, NEXT-GENERATION DRUG-COATED ANGIOPLASTY BALLOON FOR THE TREATMENT OF PERIPHERAL ARTERIAL DISEASE RECEIVES FDA APPROVAL
SINGAPORE, Nov. 11, 2022 /PRNewswire/ -- Genesis MedTech Group announced today that the Food and Drug Administration (FDA) has approved the Chocolate Touch® Drug-coated Balloon PTA Catheter, developed by TriReme Medical LLC, for the treatment of patients with peripheral artery disease in the s...
2022-11-11 14:00
2021
The new THREAD LIFT with approved design patent "TIMEMACHINE LIFT THREAD, ANCHORING DUAL COG"
SEOUL, South Korea, Nov. 10, 2022 /PRNewswire/ -- Safe thread lifting without
surgery,the most representative lifting method with various advantages
2022-11-11 12:55
1972
J INTS BIO, Novel Oral 4th Generation EGFR TKI 'JIN-A02' - Phase 1/2 IND approved by US FDA
- First patient expected in December 2022 SEOUL, South Korea, Nov. 10, 2022 /PRNewswire/ -- J INTS BIO announced on November 9th that it had received approval from the US FDA for its Phase 1/2 clinical trial of its Novel Oral 4th Generation EGFR TKI 'JIN-A02' in patients with advanced non-small ...
2022-11-11 10:30
2304
Harbour BioMed Enters into a License and Collaboration Agreement with Moderna
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Nov. 10, 2022 /PRNewswire/ -- Harbour BioMed (the "Company", HKEX: 02142) today announced that Nona Biosciences, a subsidiary wholly owned by the Company, had entered into a license and collaboration agreement with ModernaTX, Inc. (NASDA...
2022-11-11 09:03
2534
Antengene Presents Promising Results from Four Preclinical Studies at the 2022 Society for Immunotherapy of Cancer Annual Meeting
- Oral presentation highlights preclinical data with ATG-031, an in-house discovered anti-CD24 monoclonal antibody,tracking to an investigational new drug (IND) filing in H1:2023 - Three poster presentations showcase preclinical data with three programs developed or discovered in-house,ATG-1...
2022-11-11 08:30
2565
Alma Academy was Successfully Held in Dubai with the Global Launch of Alma Duo
HONG KONG, Nov. 10, 2022 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", stock code: 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global consumer wellness group, is pleased to announce that, with over 500 physicians from 47 countries around th...
2022-11-10 23:57
3257
ITRI Introduces Point-of-Care AI-DR Software for Rapid Diagnosis of Diabetic Retinopathy and Diabetic Macular Edema
Point-of-Care AI-DR is the first AI-assisted system which can be integrated
into handheld and desktop fundus cameras used to detect diabetic retinopathy
and diabetic macular edema
HSINCHU, Nov. 10, 2022 /PRNewswire/ -- The Industrial Technology Research
Institute (ITRI)
2022-11-10 22:00
2063
Week's Top Stories
Most Reposted
Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution
[Picked up by 319 media titles]
2024-11-07 09:00
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 311 media titles]
2024-11-12 09:00
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00
DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
[Picked up by 288 media titles]
2024-11-13 09:00
Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 285 media titles]
2024-11-12 11:00
Most Read
Mastercard goes OTP-free in APAC for faster, safer online transactions
2024-11-06 09:00
13462
Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution
2024-11-07 09:00
10126
XtalPi and Sinar Mas Multiartha Launch Strategic Partnership to Revolutionize AI Across Asia-Pacific
2024-11-07 11:34
7487
XTEP's First Mono Store in Malaysia Comes to Puchong
2024-11-07 10:08
6205
